March 21 (Reuters) - Endo International PLC ENDP.O :
* Endo provides statement regarding expected FDA approval of
generic Voltaren gel product
* Evaluating a number of options regarding Voltaren gel
* To provide more detail on potential financial impact of
generic entrant for Voltaren gel no later than q1 2016 earnings
presentation
Source text for Eikon: ID:nCNWp5Qhna
Further company coverage: ENDP.O